Inventor · disambiguated record
Zhijun Kang
Also filed as: KANG ZHIJUN
9 granted patents·5 pending applications·82 citations·filing 2013–2024
87Inventor score
Files withUNIV TEXAS11NAVIRE PHARMA INC2INST APPLIED CANCER SCIENCE THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CT1
Top patents by PatentIndex Score
14 records- 0196US11370786B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2020·Granted Jun 28, 2022·6 cites·17 claims
- 0295US11958849B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2022·Granted Apr 16, 2024·2 cites·12 claims
- 0395US10954243B2Substituted heterocyclic inhibitors of PTPN11NAVIRE PHARMA INC·Filed 2019·Granted Mar 23, 2021·35 cites·18 claims
- 0494US10766892B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2019·Granted Sep 8, 2020·9 cites·26 claims
- 0593US9809588B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2015·Granted Nov 7, 2017·15 cites·27 claims
- 0692US10344025B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2017·Granted Jul 9, 2019·12 cites·11 claims
- 0786US2024360121A1Gls1 inhibitors for treating diseaseUNIV TEXAS·Filed 2024·Application pending·0 cites
- 0876US10800774B2Heterocyclic inhibitors of ATR kinaseUNIV TEXAS·Filed 2018·Granted Oct 13, 2020·2 cites·25 claims
- 0974US10894052B2Heterocyclic inhibitors of ATR kinaseUNIV TEXAS·Filed 2019·Granted Jan 19, 2021·1 cites·32 claims
- 1064US2023416261A1Ethanediamine-heterocycle derivatives as inhibitors of protein arginine methyltransferasesUNIV TEXAS·Filed 2023·Application pending·0 cites
- 1161US11932643B2Substituted heterocyclic inhibitors of PTPN11NAVIRE PHARMA INC·Filed 2021·Granted Mar 19, 2024·0 cites·21 claims
- 1245US2014073634A1Heterocyclic modulators of hif activity for treatment of diseaseINST APPLIED CANCER SCIENCE THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CT·Filed 2013·Application pending·0 cites
- 1340US2016002204A1Gls1 inhibitors for treating diseaseUNIV TEXAS·Filed 2015·Application pending·0 cites
- 1435US2016002248A1Gls1 inhibitors for treating diseaseUNIV TEXAS·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Zhijun Kang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →